SurgicEye in partnership with Alkelia will present its 3-D imaging and navigation device declipseSPECT at the French-Belgian-Luxembourgish joint congress of nuclear medicine.

SurgicEye has worldwide the first 3-D handheld soft tissue imaging solution that is capable of image guided tumor resection. Use the opportunity to meet Dr. Thomas Wendler, CTO and co-founder of SugicEye GmbH at this joint congress May 7 -9, 2011 at the Kirchberg Congress Centre, Place de l’Europe, Luxembourg – Booth 9G to learn all about the application and technology that is the best radio-guided surgery solution available. To schedule an appointment please contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

The declipseSPECT is the first intra-operative device providing fully 3-D imaging and navigation during surgery. This technology makes surgical interventions safer and more reliable. The declipseSPECT is currently used to ensure the highest quality patient outcome in breast surgery and melanoma, further applications in gynecology and urology are investigated. This solution for radio-guided surgery extends one dimensional gamma probes to dimensional imaging system (imaging properties similar to SPECT), which can be flexibly used in the operating room without alteration of the clinical workflow in sentinel lymph node biopsy or primary tumors resection.